GW572016 oral tablets

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Neoplasms, Breast

Phase 1

Rollover Study Of Lapatinib In Cancer Patients

CompletedNCT00169533

GlaxoSmithKlineNeoplasms, Breast

Start: 2004-08-19End: 2009-05-05Updated: 2017-11-17

GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast Cancer

CompletedNCT00371488

GlaxoSmithKlineNeoplasms, Breast

Start: 2006-04-06End: 2007-12-10Updated: 2018-08-31